Derivative Instruments (Tables)

3 Months Ended

Jun. 30, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

As of June 30, 2019, the Company had the following derivative contracts recorded at fair value in the condensed consolidated balance sheets:

	Designated Derivative Contracts			Non-Designated Derivative Contracts			Total
Notional value	$	54,870		$	19,913		$	74,783
Fair value recorded in other accrued expenses	(417		)	(356		)	(773		)

Schedule of location and amount of gains and losses related to derivatives designated as hedging instruments reported in consolidated financial statements

The following table summarizes the effect of Designated Derivative Contracts:

	Three Months Ended June 30,
	2019			2018
Amount of (loss) gain recognized in OCI	$	(417	)	$	6,770
Amount of gain excluded from effectiveness testing recognized in SG&A expenses*	—			846

*Amounts presented for the three months ended June 30, 2018 are recognized under legacy US GAAP. Beginning April 1, 2019, under the new hedging standard, these amounts are now recognized as a component of AOCL and reclassified into earnings in accordance with the accounting policy above, however, there was no impact to earnings during the three months ended June 30, 2019.

The Company records the changes in AOCL for unrealized gains or losses on Designated Derivative Contracts net of income tax effects in the condensed consolidated statements of comprehensive loss, which were as follows:

	Three Months Ended June 30,
	2019			2018
Income tax (benefit) expense	$	(100	)	$	1,447

Schedule of location and amount of gains and losses related to derivatives not designated as hedging instruments reported in consolidated financial statements

The following table summarizes the effect of Non-Designated Derivative Contracts:

	Three Months Ended June 30,
	2019			2018
Amount of (loss) gain recognized in SG&A expenses	$	(356	)	$	487